Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-06-06
2006-06-06
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S117000, C536S118000
Reexamination Certificate
active
07056898
ABSTRACT:
Provided are compounds and compositions thereof that are useful for treating inflammation, particularly pulmonary inflammations including asthma and asthma-related pathologies such as allergy. Also provided are methods for using such compounds and compositions of the invention to treat patients suffering from, or predisposed to develop inflammation.
REFERENCES:
patent: 5827886 (1998-10-01), Hersh
patent: WO88/05301 (1988-07-01), None
Jacobsson, I. “Identification of N-sulfated disaccharide units in heparin-like polysaccharides”, Biochemical Journal, 1979, 179(1), 77-87.
Guo, Y. Analytical Biochemistry, 1988, 168, 54-62.
Shaklee, P., et al., “The Disaccharides fored by deaminative cleavage of N-deacetylated glycosaminoglycans”, Biochem J., 235(1):225-36 (1986) (abstract only).
Bienkowski, M., et al., “Structural characterization of the oligosaccharides formed by depolymerization of heparin with nitrous acid”, J. Biol. Chem., 260(1):356-65 (1985).
Hopwood, J., et al., “Selective deploymerization of dermatan sulfate: production of radiolabelled substrates for .alpha.-L-iduronidase, sulfoiduronate sulfatase, and .beta.-D-glucoronidase”, Carbohydr. Red., 122(2):227-39 (1983) (abstract only).
Edge, Albert S. B., et al., “Characterization of novel sequences containing 3-0-sulfated glucosamine i glomerular basement membrane heparan sulfate and localization of sulfated disaccharides to a peripheral domain”, J. Biol. Chem., 265(26):15874-81 (1990) (abstract only).
Shaklee, Patrick N., et al., “A Sulfatase Specific for Glucoronic Acid 2-sulfate Residues in Glycosaminoglycans”, J. Biol. Chem., 260(16):9146-9 (1985) (abstract only).
Shaklee, Patrick N., et al., “Hydrazinolysis of heparin and other glycosaminoglycans”, Biochemical Journal Portland Press, London, GB, 217, 187-197 (1984).
Ryan, G. and Majno, G., “Accute Inflammation”, Am. J. Pathol., 86:183-276 (1997).
Liles, W.C. and Van Voorhis, C., “Review: Nomenclature and biologic significance of cytokines involved in inflammation and the host immune system”, J. Infect. Dis., 172:1574-1580 (1995).
Plaut, M. and Zimmerman, E., “Allergy and Mechanisms of Hypersensitivity”, Fundamental Immunology, 3rd ed., W.E. Paul (ed.), 1399-1425, Raven Press, New York NY (1993).
Sheffer, A., et al., “The National Asthma Education program: Expert panel report guidelines for the diagnosis and management of asthma”, Med. Care, 31:MS20 (1993).
Hogg, J., “Pathology of Asthma”, Asthma as an Inflammatory Disease, O'Byrne (ed.), 1-13, Marcel Dekker, Inc., New York, NY (1990).
Cuss, F.C., “The Pathology of Antiasthma Medications”, Asthma as an Inflammatory Disease, O'Byrne (ed.), 199-250, Marcel Dekker, Inc., New York, NY (1990).
O'Byrne, P.M., “Airway Inflammation and Asthma”, Asthma as an Inflammatory Disease, O'Byrne (ed.), 143-157, Marcel Dekker, Inc., New York, NY (1990).
McFadden, E.R., “Disease of the Respiratory System”, Harrison's Principles of Internal Medicine, 14th Ed. Fauci et al. (eds.), 1419-1426, McGraw-Hill, New York, NY (1998).
Abraham, W.M., et al., “Cellular Markers of Inflammation in the Airways of Allergic Sheep with adn without Allergen-induced Late Responses”, Am. Rev. Respir. Dis., 138:1565-1571 (1988).
Palmer, et al., New Engl. J. Med., 331:1314-1319 (1994).
Bhagat, et al., “Rapid Onset of Tolerance to the Bronchoprotective Effect of Salmeterol”, Chest, 108:1235-1238 (1995).
Woolcock, A., et al., “Comparision of Addition of Salmeterol to Inhaled Steroids with Doubling of the Dose of Inhaled Steroids”, Respir. Crit. Care Med., 153:1481-1488 (1996).
Volcheck, G.W., and O'Connell, E.J., et al., “Anti-inflammatory Drugs for Controlling Asthma” Postgrad Med., 104(3):127-136 (1998).
Ahmed Tahir
Smith Gregory
Baker Norton Pharmaceuticals, Inc.
Krishnan Ganapathy
Steinberg Michael A.
Wilson James O.
LandOfFree
Hypersulfated disaccharides and methods of using the same... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypersulfated disaccharides and methods of using the same..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypersulfated disaccharides and methods of using the same... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3706929